+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Penoxsulam - Global Strategic Business Report

  • PDF Icon

    Report

  • 275 Pages
  • May 2026
  • Region: Global
  • Market Glass, Inc.
  • ID: 5310713
The global market for Penoxsulam was estimated at US$346.5 Million in 2025 and is projected to reach US$440.2 Million by 2032, growing at a CAGR of 3.5% from 2025 to 2032. This comprehensive report provides an in-depth analysis of market trends, drivers, and forecasts, helping you make informed business decisions.

Global Penoxsulam Market - Key Trends & Drivers Summarized

Why Is Penoxsulam Crucial in Agricultural Weed Management?

Penoxsulam is a selective herbicide widely used in rice paddies and other crop fields to control broadleaf weeds, sedges, and grasses. Its importance in modern agriculture lies in its ability to provide effective weed control without harming the crops themselves, thus enhancing yields and protecting the integrity of food supplies. Penoxsulam works by inhibiting the acetolactate synthase (ALS) enzyme in plants, which is critical for plant growth. This mode of action allows farmers to manage a wide range of difficult-to-control weeds while minimizing the environmental impact compared to older, more toxic herbicides. As agricultural practices modernize and the need for effective weed control increases, penoxsulam is becoming a preferred solution for weed management in various crops, particularly in Asia and Latin America.

How Are Technological Advancements Improving the Efficacy of Penoxsulam?

Technological advancements in the formulation and delivery of penoxsulam are improving its efficacy and sustainability in weed management. New formulations are being developed to provide longer-lasting control of weeds, reducing the need for repeated applications. Furthermore, advancements in precision agriculture are enabling more targeted application of penoxsulam, ensuring that only the affected areas are treated, thus reducing chemical use and minimizing environmental impact. The development of herbicide-resistant crops is also expanding the use of penoxsulam, as farmers seek to manage weeds more effectively without harming their crops. These technological innovations are making penoxsulam an increasingly versatile and efficient herbicide in modern agriculture.

What Are the Regulatory and Environmental Considerations Impacting Penoxsulam?

As with all herbicides, penoxsulam faces strict regulatory scrutiny to ensure its safety for both humans and the environment. Regulatory bodies in key agricultural regions, such as the United States, Europe, and Asia, are continually evaluating the safety and efficacy of penoxsulam, requiring manufacturers to demonstrate compliance with environmental and safety standards. Additionally, the growing emphasis on sustainable agriculture is pushing the herbicide industry to develop more eco-friendly products, with penoxsulam being favored for its relatively low toxicity compared to older herbicides. However, concerns over herbicide resistance in weeds are leading to increased research into integrated weed management practices that combine chemical, biological, and mechanical methods.

The Growth in the Penoxsulam Market Is Driven by Several Factors

The growth in the penoxsulam market is driven by several factors, including the increasing demand for effective and selective herbicides in global agriculture, particularly in rice cultivation. Technological advancements in herbicide formulation and precision application are improving the efficiency and sustainability of penoxsulam use. The expansion of herbicide-resistant crops is also contributing to the adoption of penoxsulam in more regions and crop types. Furthermore, regulatory support for sustainable and low-toxicity herbicides is boosting demand for penoxsulam as farmers seek environmentally friendly solutions to weed management. The rising awareness of the economic and environmental benefits of modern weed control practices is further driving the growth of the penoxsulam market.

Report Scope

The report analyzes the Penoxsulam market, presented in terms of market value (US$). The analysis covers the key segments and geographic regions outlined below:
  • Segments: Type (Concentrated Liquid Type, Granules Type); Organization Size (Large Enterprise Organization Size, Small & Medium Enterprises)
  • Geographic Regions/Countries: World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Key Insights:

  • Market Growth: Understand the significant growth trajectory of the Concentrated Liquid Type segment, which is expected to reach US$304.5 Million by 2032 with a CAGR of a 4.2%. The Granules Type segment is also set to grow at 1.9% CAGR over the analysis period.
  • Regional Analysis: Gain insights into the U.S. market, valued at $106.4 Million in 2025, and China, forecasted to grow at an impressive 6.9% CAGR to reach $108.8 Million by 2032. Discover growth trends in other key regions, including Japan, Canada, Germany, and the Asia-Pacific.

Why You Should Buy This Report:

  • Detailed Market Analysis: Access a thorough analysis of the Global Penoxsulam Market, covering all major geographic regions and market segments.
  • Competitive Insights: Get an overview of the competitive landscape, including the market presence of major players across different geographies.
  • Future Trends and Drivers: Understand the key trends and drivers shaping the future of the Global Penoxsulam Market.
  • Actionable Insights: Benefit from actionable insights that can help you identify new revenue opportunities and make strategic business decisions.

Key Questions Answered:

  • How is the Global Penoxsulam Market expected to evolve by 2032?
  • What are the main drivers and restraints affecting the market?
  • Which market segments will grow the most over the forecast period?
  • How will market shares for different regions and segments change by 2032?
  • Who are the leading players in the market, and what are their prospects?

Report Features:

  • Comprehensive Market Data: Independent analysis of annual sales and market forecasts in US$ Million from 2025 to 2032.
  • In-Depth Regional Analysis: Detailed insights into key markets, including the U.S., China, Japan, Canada, Europe, Asia-Pacific, Latin America, Middle East, and Africa.
  • Company Profiles: Coverage of players such as Arysta Lifescience, BASF, Bayer, Bioengineering Co., Ltd, Dow AgroSciences and more.
  • Complimentary Updates: Receive free report updates for one year to keep you informed of the latest market developments.

Some of the companies featured in this Penoxsulam market report include:

  • Arysta Lifescience
  • BASF
  • Bayer
  • Bioengineering Co., Ltd
  • Dow AgroSciences
  • DuPont
  • Hangzhou Tainlong Biotechnology Co., Ltd
  • Shijiazhuang Xingbai
  • Sumitomo Chemical
  • Syngenta

Domain Expert Insights

This market report incorporates insights from domain experts across enterprise, industry, academia, and government sectors. These insights are consolidated from multilingual multimedia sources, including text, voice, and image-based content, to provide comprehensive market intelligence and strategic perspectives. As part of this research study, the publisher tracks and analyzes insights from 43 domain experts. Clients may request access to the network of experts monitored for this report, along with the online expert insights tracker.

Table of Contents

I. METHODOLOGYII. EXECUTIVE SUMMARY
1. MARKET OVERVIEW
  • Trade Shocks, Uncertainty, and the Structural Rewiring of the Global Economy
  • How Trump’s Tariffs Impact the Market? The Big Question on Everyone’s Mind
  • How Trump’s Tariffs Impact the Market? The Big Question on Everyone’s Mind
  • Penoxsulam - Global Key Competitors Percentage Market Share in 2026 (E)
  • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2026 (E)
2. FOCUS ON SELECT PLAYERS
3. MARKET TRENDS & DRIVERS
  • Rising Demand for Herbicides in Agricultural Productivity and Weed Control
  • Increasing Adoption of Penoxsulam in Rice Cultivation Across Key Markets
  • Technological Advancements in Herbicide Formulations for Better Efficacy
  • Government Support for Sustainable Agricultural Practices Boosting Adoption
  • Growing Focus on Integrated Pest and Weed Management Solutions
  • Rising Concerns Over Herbicide Resistance Driving Innovation in Formulations
  • Expansion of Penoxsulam Use in Non-Agricultural Sectors Such as Turf Management
  • Increasing Focus on Environmental Safety and Reduced Toxicity in Herbicide Use
  • Growing Demand for Water-Efficient Crops Supported by Herbicide Use
  • Research and Development in New Applications for Penoxsulam in Diverse Crops
4. GLOBAL MARKET PERSPECTIVE
  • Table 1: World Penoxsulam Market Analysis of Annual Sales in US$ Thousand for Years 2020 through 2032
  • Table 2: World Recent Past, Current & Future Analysis for Penoxsulam by Geographic Region - USA, Canada, Japan, China, Europe, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2025 through 2032 and % CAGR
  • Table 3: World Historic Review for Penoxsulam by Geographic Region - USA, Canada, Japan, China, Europe, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
  • Table 4: World 13-Year Perspective for Penoxsulam by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Latin America, Middle East and Africa Markets for Years 2020, 2026 & 2032
  • Table 5: World Recent Past, Current & Future Analysis for Concentrated Liquid Type by Geographic Region - USA, Canada, Japan, China, Europe, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2025 through 2032 and % CAGR
  • Table 6: World Historic Review for Concentrated Liquid Type by Geographic Region - USA, Canada, Japan, China, Europe, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
  • Table 7: World 13-Year Perspective for Concentrated Liquid Type by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Latin America, Middle East and Africa for Years 2020, 2026 & 2032
  • Table 8: World Recent Past, Current & Future Analysis for Granules Type by Geographic Region - USA, Canada, Japan, China, Europe, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2025 through 2032 and % CAGR
  • Table 9: World Historic Review for Granules Type by Geographic Region - USA, Canada, Japan, China, Europe, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
  • Table 10: World 13-Year Perspective for Granules Type by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Latin America, Middle East and Africa for Years 2020, 2026 & 2032
  • Table 11: World Recent Past, Current & Future Analysis for Large Enterprise Organization Size by Geographic Region - USA, Canada, Japan, China, Europe, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2025 through 2032 and % CAGR
  • Table 12: World Historic Review for Large Enterprise Organization Size by Geographic Region - USA, Canada, Japan, China, Europe, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
  • Table 13: World 13-Year Perspective for Large Enterprise Organization Size by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Latin America, Middle East and Africa for Years 2020, 2026 & 2032
  • Table 14: World Recent Past, Current & Future Analysis for Small & Medium Enterprises by Geographic Region - USA, Canada, Japan, China, Europe, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2025 through 2032 and % CAGR
  • Table 15: World Historic Review for Small & Medium Enterprises by Geographic Region - USA, Canada, Japan, China, Europe, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
  • Table 16: World 13-Year Perspective for Small & Medium Enterprises by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Latin America, Middle East and Africa for Years 2020, 2026 & 2032
III. MARKET ANALYSIS
UNITED STATES
  • Penoxsulam Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2026 (E)
  • Table 17: USA Recent Past, Current & Future Analysis for Penoxsulam by Type - Concentrated Liquid Type and Granules Type - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
  • Table 18: USA Historic Review for Penoxsulam by Type - Concentrated Liquid Type and Granules Type Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
  • Table 19: USA 13-Year Perspective for Penoxsulam by Type - Percentage Breakdown of Value Sales for Concentrated Liquid Type and Granules Type for the Years 2020, 2026 & 2032
  • Table 20: USA Recent Past, Current & Future Analysis for Penoxsulam by Organization Size - Large Enterprise Organization Size and Small & Medium Enterprises - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
  • Table 21: USA Historic Review for Penoxsulam by Organization Size - Large Enterprise Organization Size and Small & Medium Enterprises Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
  • Table 22: USA 13-Year Perspective for Penoxsulam by Organization Size - Percentage Breakdown of Value Sales for Large Enterprise Organization Size and Small & Medium Enterprises for the Years 2020, 2026 & 2032
CANADA
  • Table 23: Canada Recent Past, Current & Future Analysis for Penoxsulam by Type - Concentrated Liquid Type and Granules Type - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
  • Table 24: Canada Historic Review for Penoxsulam by Type - Concentrated Liquid Type and Granules Type Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
  • Table 25: Canada 13-Year Perspective for Penoxsulam by Type - Percentage Breakdown of Value Sales for Concentrated Liquid Type and Granules Type for the Years 2020, 2026 & 2032
  • Table 26: Canada Recent Past, Current & Future Analysis for Penoxsulam by Organization Size - Large Enterprise Organization Size and Small & Medium Enterprises - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
  • Table 27: Canada Historic Review for Penoxsulam by Organization Size - Large Enterprise Organization Size and Small & Medium Enterprises Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
  • Table 28: Canada 13-Year Perspective for Penoxsulam by Organization Size - Percentage Breakdown of Value Sales for Large Enterprise Organization Size and Small & Medium Enterprises for the Years 2020, 2026 & 2032
JAPAN
  • Penoxsulam Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2026 (E)
  • Table 29: Japan Recent Past, Current & Future Analysis for Penoxsulam by Type - Concentrated Liquid Type and Granules Type - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
  • Table 30: Japan Historic Review for Penoxsulam by Type - Concentrated Liquid Type and Granules Type Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
  • Table 31: Japan 13-Year Perspective for Penoxsulam by Type - Percentage Breakdown of Value Sales for Concentrated Liquid Type and Granules Type for the Years 2020, 2026 & 2032
  • Table 32: Japan Recent Past, Current & Future Analysis for Penoxsulam by Organization Size - Large Enterprise Organization Size and Small & Medium Enterprises - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
  • Table 33: Japan Historic Review for Penoxsulam by Organization Size - Large Enterprise Organization Size and Small & Medium Enterprises Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
  • Table 34: Japan 13-Year Perspective for Penoxsulam by Organization Size - Percentage Breakdown of Value Sales for Large Enterprise Organization Size and Small & Medium Enterprises for the Years 2020, 2026 & 2032
CHINA
  • Penoxsulam Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2026 (E)
  • Table 35: China Recent Past, Current & Future Analysis for Penoxsulam by Type - Concentrated Liquid Type and Granules Type - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
  • Table 36: China Historic Review for Penoxsulam by Type - Concentrated Liquid Type and Granules Type Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
  • Table 37: China 13-Year Perspective for Penoxsulam by Type - Percentage Breakdown of Value Sales for Concentrated Liquid Type and Granules Type for the Years 2020, 2026 & 2032
  • Table 38: China Recent Past, Current & Future Analysis for Penoxsulam by Organization Size - Large Enterprise Organization Size and Small & Medium Enterprises - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
  • Table 39: China Historic Review for Penoxsulam by Organization Size - Large Enterprise Organization Size and Small & Medium Enterprises Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
  • Table 40: China 13-Year Perspective for Penoxsulam by Organization Size - Percentage Breakdown of Value Sales for Large Enterprise Organization Size and Small & Medium Enterprises for the Years 2020, 2026 & 2032
EUROPE
  • Penoxsulam Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2026 (E)
  • Table 41: Europe Recent Past, Current & Future Analysis for Penoxsulam by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2025 through 2032 and % CAGR
  • Table 42: Europe Historic Review for Penoxsulam by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
  • Table 43: Europe 13-Year Perspective for Penoxsulam by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2020, 2026 & 2032
  • Table 44: Europe Recent Past, Current & Future Analysis for Penoxsulam by Type - Concentrated Liquid Type and Granules Type - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
  • Table 45: Europe Historic Review for Penoxsulam by Type - Concentrated Liquid Type and Granules Type Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
  • Table 46: Europe 13-Year Perspective for Penoxsulam by Type - Percentage Breakdown of Value Sales for Concentrated Liquid Type and Granules Type for the Years 2020, 2026 & 2032
  • Table 47: Europe Recent Past, Current & Future Analysis for Penoxsulam by Organization Size - Large Enterprise Organization Size and Small & Medium Enterprises - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
  • Table 48: Europe Historic Review for Penoxsulam by Organization Size - Large Enterprise Organization Size and Small & Medium Enterprises Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
  • Table 49: Europe 13-Year Perspective for Penoxsulam by Organization Size - Percentage Breakdown of Value Sales for Large Enterprise Organization Size and Small & Medium Enterprises for the Years 2020, 2026 & 2032
FRANCE
  • Penoxsulam Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2026 (E)
  • Table 50: France Recent Past, Current & Future Analysis for Penoxsulam by Type - Concentrated Liquid Type and Granules Type - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
  • Table 51: France Historic Review for Penoxsulam by Type - Concentrated Liquid Type and Granules Type Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
  • Table 52: France 13-Year Perspective for Penoxsulam by Type - Percentage Breakdown of Value Sales for Concentrated Liquid Type and Granules Type for the Years 2020, 2026 & 2032
  • Table 53: France Recent Past, Current & Future Analysis for Penoxsulam by Organization Size - Large Enterprise Organization Size and Small & Medium Enterprises - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
  • Table 54: France Historic Review for Penoxsulam by Organization Size - Large Enterprise Organization Size and Small & Medium Enterprises Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
  • Table 55: France 13-Year Perspective for Penoxsulam by Organization Size - Percentage Breakdown of Value Sales for Large Enterprise Organization Size and Small & Medium Enterprises for the Years 2020, 2026 & 2032
GERMANY
  • Penoxsulam Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2026 (E)
  • Table 56: Germany Recent Past, Current & Future Analysis for Penoxsulam by Type - Concentrated Liquid Type and Granules Type - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
  • Table 57: Germany Historic Review for Penoxsulam by Type - Concentrated Liquid Type and Granules Type Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
  • Table 58: Germany 13-Year Perspective for Penoxsulam by Type - Percentage Breakdown of Value Sales for Concentrated Liquid Type and Granules Type for the Years 2020, 2026 & 2032
  • Table 59: Germany Recent Past, Current & Future Analysis for Penoxsulam by Organization Size - Large Enterprise Organization Size and Small & Medium Enterprises - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
  • Table 60: Germany Historic Review for Penoxsulam by Organization Size - Large Enterprise Organization Size and Small & Medium Enterprises Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
  • Table 61: Germany 13-Year Perspective for Penoxsulam by Organization Size - Percentage Breakdown of Value Sales for Large Enterprise Organization Size and Small & Medium Enterprises for the Years 2020, 2026 & 2032
ITALY
  • Table 62: Italy Recent Past, Current & Future Analysis for Penoxsulam by Type - Concentrated Liquid Type and Granules Type - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
  • Table 63: Italy Historic Review for Penoxsulam by Type - Concentrated Liquid Type and Granules Type Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
  • Table 64: Italy 13-Year Perspective for Penoxsulam by Type - Percentage Breakdown of Value Sales for Concentrated Liquid Type and Granules Type for the Years 2020, 2026 & 2032
  • Table 65: Italy Recent Past, Current & Future Analysis for Penoxsulam by Organization Size - Large Enterprise Organization Size and Small & Medium Enterprises - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
  • Table 66: Italy Historic Review for Penoxsulam by Organization Size - Large Enterprise Organization Size and Small & Medium Enterprises Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
  • Table 67: Italy 13-Year Perspective for Penoxsulam by Organization Size - Percentage Breakdown of Value Sales for Large Enterprise Organization Size and Small & Medium Enterprises for the Years 2020, 2026 & 2032
UNITED KINGDOM
  • Penoxsulam Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2026 (E)
  • Table 68: UK Recent Past, Current & Future Analysis for Penoxsulam by Type - Concentrated Liquid Type and Granules Type - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
  • Table 69: UK Historic Review for Penoxsulam by Type - Concentrated Liquid Type and Granules Type Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
  • Table 70: UK 13-Year Perspective for Penoxsulam by Type - Percentage Breakdown of Value Sales for Concentrated Liquid Type and Granules Type for the Years 2020, 2026 & 2032
  • Table 71: UK Recent Past, Current & Future Analysis for Penoxsulam by Organization Size - Large Enterprise Organization Size and Small & Medium Enterprises - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
  • Table 72: UK Historic Review for Penoxsulam by Organization Size - Large Enterprise Organization Size and Small & Medium Enterprises Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
  • Table 73: UK 13-Year Perspective for Penoxsulam by Organization Size - Percentage Breakdown of Value Sales for Large Enterprise Organization Size and Small & Medium Enterprises for the Years 2020, 2026 & 2032
SPAIN
  • Table 74: Spain Recent Past, Current & Future Analysis for Penoxsulam by Type - Concentrated Liquid Type and Granules Type - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
  • Table 75: Spain Historic Review for Penoxsulam by Type - Concentrated Liquid Type and Granules Type Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
  • Table 76: Spain 13-Year Perspective for Penoxsulam by Type - Percentage Breakdown of Value Sales for Concentrated Liquid Type and Granules Type for the Years 2020, 2026 & 2032
  • Table 77: Spain Recent Past, Current & Future Analysis for Penoxsulam by Organization Size - Large Enterprise Organization Size and Small & Medium Enterprises - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
  • Table 78: Spain Historic Review for Penoxsulam by Organization Size - Large Enterprise Organization Size and Small & Medium Enterprises Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
  • Table 79: Spain 13-Year Perspective for Penoxsulam by Organization Size - Percentage Breakdown of Value Sales for Large Enterprise Organization Size and Small & Medium Enterprises for the Years 2020, 2026 & 2032
RUSSIA
  • Table 80: Russia Recent Past, Current & Future Analysis for Penoxsulam by Type - Concentrated Liquid Type and Granules Type - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
  • Table 81: Russia Historic Review for Penoxsulam by Type - Concentrated Liquid Type and Granules Type Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
  • Table 82: Russia 13-Year Perspective for Penoxsulam by Type - Percentage Breakdown of Value Sales for Concentrated Liquid Type and Granules Type for the Years 2020, 2026 & 2032
  • Table 83: Russia Recent Past, Current & Future Analysis for Penoxsulam by Organization Size - Large Enterprise Organization Size and Small & Medium Enterprises - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
  • Table 84: Russia Historic Review for Penoxsulam by Organization Size - Large Enterprise Organization Size and Small & Medium Enterprises Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
  • Table 85: Russia 13-Year Perspective for Penoxsulam by Organization Size - Percentage Breakdown of Value Sales for Large Enterprise Organization Size and Small & Medium Enterprises for the Years 2020, 2026 & 2032
REST OF EUROPE
  • Table 86: Rest of Europe Recent Past, Current & Future Analysis for Penoxsulam by Type - Concentrated Liquid Type and Granules Type - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
  • Table 87: Rest of Europe Historic Review for Penoxsulam by Type - Concentrated Liquid Type and Granules Type Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
  • Table 88: Rest of Europe 13-Year Perspective for Penoxsulam by Type - Percentage Breakdown of Value Sales for Concentrated Liquid Type and Granules Type for the Years 2020, 2026 & 2032
  • Table 89: Rest of Europe Recent Past, Current & Future Analysis for Penoxsulam by Organization Size - Large Enterprise Organization Size and Small & Medium Enterprises - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
  • Table 90: Rest of Europe Historic Review for Penoxsulam by Organization Size - Large Enterprise Organization Size and Small & Medium Enterprises Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
  • Table 91: Rest of Europe 13-Year Perspective for Penoxsulam by Organization Size - Percentage Breakdown of Value Sales for Large Enterprise Organization Size and Small & Medium Enterprises for the Years 2020, 2026 & 2032
AUSTRALIA
  • Penoxsulam Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2026 (E)
INDIA
  • Penoxsulam Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2026 (E)
SOUTH KOREA
REST OF ASIA-PACIFIC
LATIN AMERICA
  • Penoxsulam Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2026 (E)
ARGENTINA
BRAZIL
MEXICO
REST OF LATIN AMERICA
MIDDLE EAST
  • Penoxsulam Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2026 (E)
IRAN
ISRAEL
SAUDI ARABIA
UNITED ARAB EMIRATES
REST OF MIDDLE EAST
AFRICA
  • Penoxsulam Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2026 (E)
IV. COMPETITION

Companies Mentioned (Partial List)

A selection of companies mentioned in this report includes, but is not limited to:

  • Arysta Lifescience
  • BASF
  • Bayer
  • Bioengineering Co., Ltd
  • Dow AgroSciences
  • DuPont
  • Hangzhou Tainlong Biotechnology Co., Ltd
  • Shijiazhuang Xingbai
  • Sumitomo Chemical
  • Syngenta

Table Information